India, Aug. 25 -- Zymeworks Inc. (ZYME), a biotechnology company, announced on Tuesday receipt of approval from the U.S. Food and Drug Administration (FDA) for Ziihera in two combination regimens for ... Read More
India, Aug. 25 -- NVIDIA Corp. (NVDA), an American technology company, on Tuesday announced Jetson Orin Nano 2, a new robotics computer aimed at entry-level edge AI applications, promising twice the i... Read More
India, Aug. 25 -- Biodesix, Inc. (BDSX), a diagnostic solutions company focused on lung disease, touched a new 52-week high of $29.18 in today's trading. The stock has surged over 90% over the past th... Read More
India, Aug. 25 -- Uber Technology (UBER) has launched a live video streaming feature for teen accounts, allowing linked parents or guardians to watch rides in real time through the driver's phone came... Read More
India, Aug. 25 -- AbCellera Biologics Inc. (ABCL), a clinical-stage biotechnology company developing antibody-based medicines, recently reported second-quarter 2026 financial results and provided upda... Read More
India, Aug. 25 -- Rhino is dialing up another righteous Rocktober, with 54 limited-edition vinyl releases dropping on select Fridays all month long, starting October 2. This year's lineup is stacked ... Read More
India, Aug. 24 -- Members of the United Auto Workers at John Deere (DE) have voted to reject the company's proposal to extend their current collective bargaining agreement through 2029. The proposal,... Read More
India, Aug. 24 -- Jazz Pharmaceuticals plc (JAZZ) is set to face a pivotal FDA decision on August 25, 2026, for its drug candidate Ziihera. Ziihera (zanidatamab-hrii) is a HER2-targeted bispecific an... Read More
India, Aug. 24 -- Bitcoin has inched close to $80k and cryptocurrencies are trading firmly in the green amidst a mixed global market scenario. The CMC Crypto Fear and Greed Index that tracks sentimen... Read More
India, Aug. 24 -- REGENXBIO Inc. (RGNX) shares plunged 26% to $7.96 in Monday's trading after the company said the FDA placed a clinical hold on its investigational RGX-121 gene therapy for MPS II, or... Read More